Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Covington
Cerilliant
McKinsey
US Department of Justice
UBS
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
McKesson

Generated: February 20, 2018

DrugPatentWatch Database Preview

DIMENHYDRINATE Drug Profile

« Back to Dashboard

Drug patent expirations by year for DIMENHYDRINATE
Medical Subject Heading (MeSH) Categories for DIMENHYDRINATE

US Patents and Regulatory Information for DIMENHYDRINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare DIMENHYDRINATE dimenhydrinate INJECTABLE;INJECTION 084767-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Heather DIMENHYDRINATE dimenhydrinate TABLET;ORAL 080841-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs Teva DIMENHYDRINATE dimenhydrinate INJECTABLE;INJECTION 080615-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Nexgen Pharma Inc DIMENHYDRINATE dimenhydrinate TABLET;ORAL 085985-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa DIMENHYDRINATE dimenhydrinate INJECTABLE;INJECTION 040519-001 Jun 23, 2004 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs DIMENHYDRINATE dimenhydrinate INJECTABLE;INJECTION 083531-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alra DIMENHYDRINATE dimenhydrinate LIQUID;ORAL 080715-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst DIMENHYDRINATE dimenhydrinate INJECTABLE;INJECTION 084316-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs DIMENHYDRINATE dimenhydrinate TABLET;ORAL 085166-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Teva
Citi
US Department of Justice
Mallinckrodt
Chubb
Covington
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot